Article Versions Notes

Möller M, Wasel J, Schmetzer J, Weiß U, Meissner M, Schiffmann S, Weigert A, Möser CV, Niederberger E. The Specific IKKε/TBK1 Inhibitor Amlexanox Suppresses Human Melanoma by the Inhibition of Autophagy, NF-κB and MAP Kinase Pathways. International Journal of Molecular Sciences. 2020; 21(13):4721. https://doi.org/10.3390/ijms21134721

Möller, Moritz, Julia Wasel, Julia Schmetzer, Ulrike Weiß, Markus Meissner, Susanne Schiffmann, Andreas Weigert, Christine V. Möser, and Ellen Niederberger. 2020. "The Specific IKKε/TBK1 Inhibitor Amlexanox Suppresses Human Melanoma by the Inhibition of Autophagy, NF-κB and MAP Kinase Pathways" International Journal of Molecular Sciences 21, no. 13: 4721. https://doi.org/10.3390/ijms21134721

Möller, M., Wasel, J., Schmetzer, J., Weiß, U., Meissner, M., Schiffmann, S., Weigert, A., Möser, C. V., & Niederberger, E. (2020). The Specific IKKε/TBK1 Inhibitor Amlexanox Suppresses Human Melanoma by the Inhibition of Autophagy, NF-κB and MAP Kinase Pathways. International Journal of Molecular Sciences, 21(13), 4721. https://doi.org/10.3390/ijms21134721